Cardiovascular Disease Guidelines for Diabetes Medications
October 29th 2021Muthiah Vaduganathan, MD, MPH, provides insight into cardiology guidelines for the use of SGLT-2 [sodium-glucose cotransporter-2] inhibitors and GLP-1 [glucagon-like peptide-1] receptor agonists and discusses the uptake of these medications in patients with and without diabetes.
Continuous Glucose Monitors in Type 1 and Type 2 Diabetes
A panel of experts discuss the impact of continuous glucose monitoring (CGM) on individualized patient care plans for patients with type 1 and type 2 diabetes.
Robert Busch, MD, and Diana Issacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, provide insight into the use of insulin pumps in type 2 diabetes and describe currently available smart pumps.
Role of Technology in Diabetes Care
Dhiren Patel, PharmD, CDE, BC-ADM, BCACP; Robert Busch, MD; and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, provide an overview of the pillars of technology utilized in diabetes care: Continuous glucose monitors (CGMs), smart insulin pumps, and connected insulin pens.
Addressing Influenza in the COVID-19 Era
A group of experts led by Tina Q. Tan, MD, FAAP, FIDSA, FDIPS, discuss how best to address influenza prevention, identification, and treatment in the COVID-19 era and beyond.